These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19151017)

  • 1. Azathioprine for multiple sclerosis.
    Casetta I; Iuliano G; Filippini G
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):131-2; discussion 132. PubMed ID: 19151017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine for multiple sclerosis.
    Casetta I; Iuliano G; Filippini G
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003982. PubMed ID: 17943809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
    Confavreux C; Saddier P; Grimaud J; Moreau T; Adeleine P; Aimard G
    Neurology; 1996 Jun; 46(6):1607-12. PubMed ID: 8649558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging treatments in multiple sclerosis: azathioprine and mofetil.
    Confavreux C; Moreau T
    Mult Scler; 1996 Jul; 1(6):379-84. PubMed ID: 9345422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive treatments in MS--side effects from azathioprine.
    Craner MJ; Zajicek JP
    J Neurol; 2001 Jul; 248(7):625-6. PubMed ID: 11518009
    [No Abstract]   [Full Text] [Related]  

  • 7. Azathioprine. Safety profile in multiple sclerosis patients.
    La Mantia L; Mascoli N; Milanese C
    Neurol Sci; 2007 Dec; 28(6):299-303. PubMed ID: 18175075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined immunoglobulin and azathioprine in multiple sclerosis.
    Kalanie H; Tabatabai SS
    Eur Neurol; 1998; 39(3):178-81. PubMed ID: 9605396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study.
    Fernández O; Guerrero M; Mayorga C; Muñoz L; Leán A; Luque G; Hervás M; Fernández V; Capdevila A; de Ramón E
    J Neurol; 2002 Aug; 249(8):1058-62. PubMed ID: 12195454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.
    Kalincik T; Horakova D; Dolezal O; Krasensky J; Vaneckova M; Seidl Z; Havrdova E
    Clin Neurol Neurosurg; 2012 Sep; 114(7):940-6. PubMed ID: 22402204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.
    Massacesi L; Tramacere I; Amoroso S; Battaglia MA; Benedetti MD; Filippini G; La Mantia L; Repice A; Solari A; Tedeschi G; Milanese C
    PLoS One; 2014; 9(11):e113371. PubMed ID: 25402490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment.
    Lus G; Romano F; Scuotto A; Accardo C; Cotrufo R
    Eur Neurol; 2004; 51(1):15-20. PubMed ID: 14631124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of azathioprine treatment in multiple sclerosis.
    Yudkin PL; Ellison GW; Ghezzi A; Goodkin DE; Hughes RA; McPherson K; Mertin J; Milanese C
    Lancet; 1991 Oct; 338(8774):1051-5. PubMed ID: 1681364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis.
    Putzki N; Knipp S; Ramczykowski T; Vago S; Germing U; Diener HC; Limmroth V
    Mult Scler; 2006 Jun; 12(3):363-6. PubMed ID: 16764353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific immunosuppressants in the treatment of multiple sclerosis.
    Confavreux C; Vukusic S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis.
    Pulicken M; Bash CN; Costello K; Said A; Cuffari C; Wilterdink JL; Rogg JM; Mills P; Calabresi PA
    Mult Scler; 2005 Apr; 11(2):169-74. PubMed ID: 15794390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together.
    Messori A; Fadda V; Maratea D; Trippoli S
    J Neurol Sci; 2014 Dec; 347(1-2):408-10. PubMed ID: 25455308
    [No Abstract]   [Full Text] [Related]  

  • 20. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.
    Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Syndulko K; Holevoet-Howson MI; Lerner CD; Frane MV; Pettler-Jennings P
    Neurology; 1989 Aug; 39(8):1018-26. PubMed ID: 2668784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.